Long-Sheng Lu received M.D. (2000) and Ph.D. (2007) in pharmacology from National Taiwan University, followed by postdoctoral training in molecular and cellular oncocardiology in M.D. Anderson Cancer Center / Texas Heart Institute (2007-2012). After joining Taipei Medical University for resident training in radiation oncology (2012), he is now a staff radiation oncologist (2017-) and an assistant professor in biomedical materials and tissue engineering (2015-). Dr. Lu is interested in translational radiation oncology and personalized cancer medicine. With clinical specialty in breast and gastrointestinal cancers, his research is aiming at cardiopulmonary protection and radiation-assisted immunotherapy. Moreover, he initiated and sat in the molecular tumor board of TMU (2018-) and developed microfluidic circulating tumor cell technologies for personalized cancer medicine. Dr. Lu has published 30 SCI papers, 2 book chapters and holds 5 patents. In recent 3 years, he has been invited to speak in more than 8 international conferences and universities in United States, India, Japan, China and Taiwan. Dr. Lu received academic and innovative entrepreneurship awards including Junior Faculty Career Development Award from Taiwan Society for Therapeutic and Radiation Oncology (2018), National Innovation Award (2019) and FITI Entrepreneurship Award (2017, 2018) from Taiwanese Ministry of science and technology.